Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Progress in Neuro-psychopharmacology and Biological Psychiatry

• Publication date

  1994-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0278-5846(94)90102-3PMID 7972857
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

  2005cited by this paper
• (3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

  2005cited by this paper
• Depolarization inactivation of dopamine neurons: Terminal release characteristics

  1993cited by this paper
• Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens.

  1993cited by this paper
• Stress Preferentially Increases Extraneuronal Levels of Excitatory Amino Acids in the Prefrontal Cortex: Comparison to Hippocampus and Basal Ganglia

  1993cited by this paper
• Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats.

  1993cited by this paper
• Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area

  1992cited by this paper
• Dopaminergic Modulation of Glutamate Release in Striatum as Measured by Microdialysis

  1992cited by this paper
• Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input.

  1992cited by this paper
• Tonic inhibition of striatal dopamine transmission: effects of benzodiazepine and GABAA receptor antagonists on extracellular dopamine levels.

  1992cited by this paper
• Decreased hippocampal expression of a glutamate receptor gene in schizophrenia.

  1991cited by this paper
• Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum

  1991cited by this paper
• Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia.

  1991cited by this paper
• Recent advances in the phencyclidine model of schizophrenia.

  1991cited by this paper
• Clozapine attenuates N-methyl-D-aspartate receptor complex-mediated responses in vivo: tentative evidence for a functional modulation by a noradrenergic mechanism.

  1991cited by this paper
• Do endogenous excitatory amino acids influence striatal dopamine release?

  1991cited by this paper
• Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.

  1991cited by this paper
• Glutamate Receptors of a Quisqualate‐Kainate Subtype are Involved in the Presynaptic Regulation of Dopamine Release in the Cat Caudate Nucleus in vivo

  1990cited by this paper
• Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices

  1990cited by this paper
• NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

  1990cited by this paper
• Glutamate: a new target in schizophrenia?

  1990cited by this paper
• The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function.

  1990cited by this paper
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

  1990cited by this paper
• Excitotoxic amino acids and neuropsychiatric disorders.

  1990cited by this paper
• Effect of L-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies.

  1990cited by this paper
• Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract‐tracing study with Phaseolus vulgaris leucoagglutinin

  1989cited by this paper
• An hypothesis regarding the antipsychotic effect of neuroleptic drugs.

  1989cited by this paper
• Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia

  1989cited by this paper
• Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen.

  1989cited by this paper
• Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release.

  1989cited by this paper
• Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis.

  1989cited by this paper
• Effect of Ischemia on the In Vivo Release of Striatal Dopamine, Glutamate, and γ‐Aminobutyric Acid Studied by Intracerebral Microdialysis

  1988cited by this paper
• Schizophrenia and the frontal lobe.

  1988cited by this paper
• Quisqualate, kainate and NMDA can initiate spreading depression in the turtle cerebellum.

  1988cited by this paper
• Biphasic modulation of evoked [3H]D‐aspartate release by D‐2 dopamine receptors in rat striatal slices

  1988cited by this paper
• Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.

  1988cited by this paper
• Differential Control by N‐Methyl‐D‐Aspartate and Kainate of Striatal Dopamine Release In Vivo: A Trans‐Striatal Dialysis Study

  1988cited by this paper
• Implications of normal brain development for the pathogenesis of schizophrenia.

  1987cited by this paper
• Non-competitive antagonists of excitatory amino acid receptors

  1987cited by this paper
• Temporal relationship between neurotransmitter release and ion flux during spreading depression and anoxia.

  1987cited by this paper
• Presynaptic dopaminergic modulation of cortical input to the striatum.

  1986cited by this paper
• In vivo presynaptic control of dopamine release in the cat caudate nucleus--II. Facilitatory or inhibitory influence of L-glutamate.

  1986cited by this paper
• Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum.

  1984cited by this paper
• Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

  1984cited by this paper
• Excitatory input from sensory motor cortex to neostriatum and its modification by conditioning stimulation of the substantia nigra.

  1984cited by this paper
• Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia.

  1983cited by this paper
• Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.

  1980cited by this paper
• Convergent prefrontal and nigral projections to the striatum of the rat.

  1979cited by this paper
• STIMULATORY EFFECT OF l‐GLUTAMATE AND RELATED AMINO ACIDS ON [3H]DOPAMINE RELEASE FROM RAT STRIATUM: AN IN VITRO MODEL FOR GLUTAMATE ACTIONS

  1979cited by this paper
• Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity.

  1978cited by this paper
• Selective activation of the mesocortical DA system by stress

  1976cited by this paper
• Dopaminergic Terminals in the Rat Cortex

  1973cited by this paper
• Quantitative histological analysis of the cerebellar cortex in the cat. I. Number and arrangement in space of the Purkinje cells.

  1971cited by this paper
• Study of a new schizophrenomimetic drug; sernyl.

  1959cited by this paper

• Simultaneous determination of human plasma 5 amino acid neurotransmitters using liquid chromatography-tandem mass spectrometry: establishment of reference intervals in Chinese adult population and application to patients with schizophrenia.

  2023cites this paper
• A Quantitative System Pharmacology Computer Model for Cognitive Deficits in Schizophrenia

  2013cites this paper
• Mangiferin ameliorates 6-hydroxydopamine-induced cytotoxicity and oxidative stress in ketamine model of schizophrenia

  2012cites this paper
• Preweaning Sensorimotor Deficits and Adolescent Hypersociability in Grin1 Knockdown Mice

  2012cites this paper
• Cerebellar dentate nuclei lesions reduce motivation in appetitive operant conditioning and open field exploration.

  2011cites this paper
• RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia

  2010cites this paper
• Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat.

  2010cites this paper
• Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia

  2009cites this paper
• Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease

  2008cites this paper
• Role of endogenous sleep‐wake and analgesic systems in anesthesia

  2008cites this paper
• Activities of the Antipsychotic Drugs Haloperidol and Risperidone on Behavioural Effects Induced by Ketamine in Mice

  2008cites this paper
• Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia.

  2007cites this paper
• σ Receptors and Scizophrenia

  2007cites this paper
• Depolarization-induced, glutamate receptor-mediated, and transactivation-dependent extracellular-signal regulated kinase phosphorylation in cultured cerebellar granule neurons.

  2007cites this paper
• Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.

  2006cites this paper
• LY3 54740: A Systemically Active mGlu2/mGlu3 Receptor Agonist

  2006cites this paper
• Effects of haloperidol and clozapine on glutamate release from nerve terminals isolated from rat prefrontal cortex

  2005cites this paper
• Progressive ratio performance following challenge with antipsychotics, amphetamine, or NMDA antagonists in adult rats treated perinatally with phencyclidine

  2004cites this paper
• Synaptic basis of persistent activity in prefrontal cortex in vivo and in organotypic cultures.

  2003cites this paper
• Pharmacological challenge reveals long-term effects of perinatal phencyclidine on delayed spatial alternation in rats.

  2003cites this paper
• Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia.

  2003cites this paper
• Repeated cocaine administration differentially affects NMDA receptor subunit (NR1, NR2A‐C) mRNAs in rat brain

  2002cites this paper
• Phencyclidine supersensitivity in rats with neonatal dopamine loss

  2002cites this paper
• Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness.

  2002cites this paper
• Effects of pre‐ and postnatal corticosterone exposure on the rat hippocampal GABA system

  2001cites this paper
• Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

  2001cites this paper
• Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

  2000cites this paper
• Linkage and associated studies of schizophrenia.

  2000cites this paper
• A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences

  2000cites this paper
• Regulation of Ionotropic Glutamate Receptor Subunits in Different Rat Brain Areas by a Preferential Sigma1 Receptor Ligand and Potential Atypical Antipsychotic

  2000cites this paper
• Locomotion elicited by MK801 in developing and adult rats: temporal, environmental, and gender effects.

  1999cites this paper
• LY 354740 : A Systemically Active mGlu 2 / mGlu 3 Receptor Agonist

  1999cites this paper
• Animal Models of Negative Symptoms: M100907 Antagonizes PCP-Induced Immobility in a Forced Swim Test in Mice

  1999cites this paper
• The locomotor effects of MK801 in the nucleus accumbens of developing and adult rats.

  1999cites this paper
• The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

  1999cites this paper
• Enhancement of N‐methyl‐D‐aspartate (NMDA) immunoreactivity in residual dendritic spines in the caudate‐putamen nucleus after chronic haloperidol administration

  1999cites this paper
• The delayed effects of phencyclidine enhance amphetamine-induced behavior and striatal C-Fos expression in the rat.

  1999cites this paper
• The Effects of M100907 in Pharmacological and Developmental Animal Models of Prepulse Inhibition Deficits in Schizophrenia

  1999cites this paper
• Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia

  1999cites this paper
• Characterization of MK-801-induced behavior as a putative rat model of psychosis.

  1999cites this paper
• Neuroleptics with differential affinities at dopamine D2 receptors and sigma receptors affect differently the N‐methyl‐D‐aspartate‐induced increase in intracellular calcium concentration: Involvement of protein kinase

  1999cites this paper
• Glutamate receptors in the mammalian central nervous system.

  1998cites this paper
• Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach

  1998cites this paper
• Expression of messenger RNAs encoding ionotropic glutamate receptors in rat brain: regulation by haloperidol.

  1998cites this paper
• M100907, A Selective 5-HT2A Receptor Antagonist and a Potential Antipsychotic Drug, Facilitates N-Methyl-D-Aspartate–Receptor Mediated Neurotransmission in the Rat Medial Prefrontal Cortical Neurons In Vitro

  1998cites this paper
• M100907 and Clozapine, but not Haloperidol or Raclopride, Prevent Phencyclidine-Induced Blockade of NMDA Responses in Pyramidal Neurons of the Rat Medial Prefrontal Cortical Slice

  1998cites this paper
• Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia.

  1997cites this paper
• Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro.

  1997cites this paper
• Adenosine A1 and A2 receptor agonists significantly prevent the electroencephalographic effects induced by MK-801 in rats.

  1997cites this paper
• Behavioral pharmacology of N-methyl-D-aspartate antagonists: implications for the study and pharmacotherapy of anxiety and schizophrenia.

  1997cites this paper
• Immunoautoradiographic evidence for a loss of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia

  1997cites this paper
• A linkage study of the N‐methyl‐D‐aspartate receptor subunit gene loci and schizophrenia in southern African Bantu‐speaking families

  1997cites this paper
• Cortical regulation of subcortical dopamine neurotransmission: contributions of glutamatergic mechanisms

  1996cites this paper
• Theta/gamma networks with slow NMDA channels learn sequences and encode episodic memory: role of NMDA channels in recall.

  1996cites this paper
• Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens.

  1996cites this paper
• Pharmacological actions of the atypical antipsychotic drug clozapine: A review

  1996cites this paper
• Regulation of glutamate efflux by excitatory amino acid receptors: evidence for tonic inhibitory and phasic excitatory regulation.

  1995cites this paper
• Glutamate agonist activity: implications for antipsychotic drug action and schizophrenia

  1995cites this paper
• Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs

  1995cites this paper